| | Title | Author(s) | Year | View Count | | 1 |  | Anti-tumor efficacy of recombinant human arginase in combination with chemotherapeutic agents in human hepatocellular carcinoma | Chow, AKM; Pang, R; Chu, ACY; Ng, L; Poon, RTP; Cheng, NM | 2011 | 268 |
| 2 | | Detection of CD44+ cancer initiating cells in pleural effusion of a liver cancer patient | Chow, AKM; Poon, RTP; Ng, R; Chiu, L; Chan, S; Pang, RWC | 2011 | 127 |
| 3 |  | Anti-tumor efficacy of a recombinant human arginase in combination with chemotherapeutic agents in human hepatocellular carcinoma | Chow, A; Pang, R; Chu, A; Ng, L; Poon, R | 2011 | 308 |
| 4 | | Enhanced therapeutic efficacy of transarterial chemoembolisation treatment in hepatocelluar carcinoma (HCC) by mTOR inhibitor RAD001: implication for a novel treatment regimen in HCC | Chu, ACY; Poon, RTP; Lam, SC; Chow, KM; Pang, R | 2011 | 149 |
| 5 |  | A phase I/II study of Foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2 and VEGFR in advanced hepatocellular carcinoma (HCC) | Yau, TCC; Sukeepaisarnjaroen, W; Chao, Y; Yen, CJ; Lausoontornsiri, W; Chen, PJ; Sanpajit, T; Lencioni, R; Camp, A; Kallender, H; Ottesen, LH; Poon, RTP | 2011 | 67 |
| 6 | | A randomized, double-blind, placebo-controlled, ascending dose trial of the pharmacokinetics and safety of intravenous infusion of recombinant human plasma gelsolin in acutely ill patients with decreased plasma gelsolin levels | Chan, WM; Lau, LS; Kwok, KM; Law, WL; Ho, JCM; Chu, KM; Poon, RTP | 2011 | 55 |
| 7 | | Overexpression of miR106b promotes metastasis in hepatocellular carcinoma by activating epithelialmesenchymal transition process | Yau, WL; Pang, RWC; Lee, TKW; Lam, CSC; Wo, JYH; Ng, L; Chan, JYK; Chow, AKM; Ng, KTP; Man, K; Poon, RTP | 2011 | 63 |
| 8 | | Asian consensus workshop report: Expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia | Han, KH; Kudo, M; Ye, SL; Choi, JY; Poon, RTP; Seong, J; Park, JW; Ichida, T; Chung, JW; Chow, P; Cheng, AL | 2011 | 73 |
| 9 | | Rapid measurement of indocyanine green clearance by pulse spectrophotometry: a validation study in 70 patients with Child-pugh A liver function | Cheung, TT; Chan, SC; Poon, RTP; Lo, CM; Fan, ST | 2011 | 148 |
| 10 | | High intensity focused ultrasound therapy: a new treatment on the horizon for hepatocellular carcinoma | Chan, A; Fan, ST; Cheung, TT; Poon, R; Lo, CM | 2011 | 169 |
| 11 | | Safety and tolerance of high intensive focused ultrasound ablation for hepatocellular carcinoma in 100 consecutive patients | Cheung, TT; Poon, RTP; Lo, CM; Fan, ST | 2011 | 145 |
| 12 | | Defining an optimal surgical strategy for treatment of recurrent hepatocellular carcinoma after hepatectomy: re-resection or radiofrequency ablation? | Chan, A; Poon, R; Cheung, TT; Lo, CM; Fan, ST | 2011 | 126 |
| 13 | | Acute phase liver graft injury significantly mobilized circulating endothelial progenitor cells, myeloid-derived suppressor cells and regulatory T cells | Ling, C; Lo, CM; Liu, X; Ng, KTP; Li, C; Leung, A; Fan, ST; Poon, RTP; Man, K | 2010 | 325 |
| 14 | | Actopaxin: a novel regulator of cell migration and invasion in human hepatocellular carcinoma | Ng, L; Yau, WL; Poon, RTP; Wong, BCY; Pang, R | 2010 | 314 |
| 15 | | Serum level of DKK1 as a marker for predicting tumor recurrence of hepatocellular carcinoma | Tung, EKK; Mak, CKM; Lee, JMF; Li, JJ; Poon, RTP; Lai, CL; Luk, JMC; Ng, IOL | 2010 | 1,137 |
| 16 | | Impact of antiviral therapy on the survival outcome of patients after hepatectomy for hepatitis B-related hepatocellular carcinoma | Chan, A; Chok, SH; Yuen, WK; Chan, SC; Ng, KKC; Poon, RTP; Lo, CM; Fan, ST | 2010 | 287 |
| 17 | | The proangiogenic role of brain-derived neurotrophic factor in tumor development | Lam, CT; Yang, ZF; Fan, ST; Poon, RTP | 2010 | 161 |
| 18 | | Discruption of akt/hif1 signaling can enhance the therapeutic efficacy of ischemic hypoxia and chemotherapy | Lau, CK; Yang, ZF; Ho, WY; Ng, M; Poon, TP; Fan, ST | 2010 | 161 |
| 19 | | The potential role of early-phase graft injury in induction of late-phase chemoresistance after liver transplantation | Geng, W; Man, K; Cheng, Q; Ng, KTP; Liu, XB; Liu, Y; Poon, RTP; Fan, ST; Lo, CM | 2010 | 169 |
| 20 | | Inhibition of tumour growth by Raf265 via blockade of Raf/MEK/ERK pathway in colorectal cancer | Chow, AKM; Chu, ACY; Poon, RTP; Wong, BCY; Pang, RWC | 2010 | 220 |
|
